Latest newsView all news
Expansion of the Pathology Range with RevMAb antibodies
January 16, 2015 - RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma.
Exclusive products from ESI BIO, now available
January 15, 2015 - Sanbio signed an exclusive contract with ESI BIO, division of BioTime Inc. The breakthrough stem cell technologies, light the path from research to clinic in order to help our customers with their goal of treating disease.
- NVVI 2015 meeting http://t.co/Yl2i4fweRg March 27, 2015 - Sanbio B.V.
- RT @barrysanbio: Our yearly booth at the Dutch Immunology Meeting, Lunteren with @SanbioBV and our @HycultBiotech friends! #nvvi http://t.c… March 26, 2015 - Sanbio B.V.
- RT @barrysanbio: Come and meet us the @SanbioBV booth during the #NVVI meeting and grap your @CaymanChemical #RESEARCH t-shirt! http://t.co… March 26, 2015 - Sanbio B.V.